These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 30717414)

  • 21. Overexpression of stearoyl-coenzyme A desaturase 1 in macrophages promotes reverse cholesterol transport.
    Nakaya K; Ayaori M; Uto-Kondo H; Sotherden GM; Nishida T; Katamoto H; Miura Y; Takiguchi S; Yakushiji E; Iizuka M; Ogura M; Sasaki M; Yogo M; Komatsu T; Adachi T; Maruyama C; Ikewaki K
    Biochim Biophys Acta; 2013 Aug; 1831(8):1402-11. PubMed ID: 23747827
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of native and myeloperoxidase-modified apolipoprotein a-I on reverse cholesterol transport and atherosclerosis in mice.
    Hewing B; Parathath S; Barrett T; Chung WK; Astudillo YM; Hamada T; Ramkhelawon B; Tallant TC; Yusufishaq MS; Didonato JA; Huang Y; Buffa J; Berisha SZ; Smith JD; Hazen SL; Fisher EA
    Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):779-89. PubMed ID: 24407029
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aerobic exercise training enhances the in vivo cholesterol trafficking from macrophages to the liver independently of changes in the expression of genes involved in lipid flux in macrophages and aorta.
    Pinto PR; Rocco DD; Okuda LS; Machado-Lima A; Castilho G; da Silva KS; Gomes DJ; Pinto Rde S; Iborra RT; Ferreira Gda S; Nakandakare ER; Machado UF; Correa-Giannella ML; Catanozi S; Passarelli M
    Lipids Health Dis; 2015 Sep; 14():109. PubMed ID: 26377330
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CETP activity variation in mice does not affect two major HDL antiatherogenic properties: macrophage-specific reverse cholesterol transport and LDL antioxidant protection.
    Rotllan N; Calpe-Berdiel L; Guillaumet-Adkins A; Süren-Castillo S; Blanco-Vaca F; Escolà-Gil JC
    Atherosclerosis; 2008 Feb; 196(2):505-13. PubMed ID: 17588582
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methionine-induced hyperhomocysteinemia impairs the antioxidant ability of high-density lipoproteins without reducing in vivo macrophage-specific reverse cholesterol transport.
    Julve J; Escolà-Gil JC; Rodríguez-Millán E; Martín-Campos JM; Jauhiainen M; Quesada H; Rentería-Obregón IM; Osada J; Sánchez-Quesada JL; Blanco-Vaca F
    Mol Nutr Food Res; 2013 Oct; 57(10):1814-24. PubMed ID: 23754667
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Macrophage reverse cholesterol transport in mice expressing ApoA-I Milano.
    Alexander ET; Weibel GL; Joshi MR; Vedhachalam C; de la Llera-Moya M; Rothblat GH; Phillips MC; Rader DJ
    Arterioscler Thromb Vasc Biol; 2009 Oct; 29(10):1496-501. PubMed ID: 19661486
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Liver ABCA1 deletion in LDLrKO mice does not impair macrophage reverse cholesterol transport or exacerbate atherogenesis.
    Bi X; Zhu X; Duong M; Boudyguina EY; Wilson MD; Gebre AK; Parks JS
    Arterioscler Thromb Vasc Biol; 2013 Oct; 33(10):2288-96. PubMed ID: 23814116
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genome-wide screen for modulation of hepatic apolipoprotein A-I (ApoA-I) secretion.
    Miles RR; Perry W; Haas JV; Mosior MK; N'Cho M; Wang JW; Yu P; Calley J; Yue Y; Carter Q; Han B; Foxworthy P; Kowala MC; Ryan TP; Solenberg PJ; Michael LF
    J Biol Chem; 2013 Mar; 288(9):6386-96. PubMed ID: 23322769
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lecithin: cholesterol acyltransferase expression has minimal effects on macrophage reverse cholesterol transport in vivo.
    Tanigawa H; Billheimer JT; Tohyama J; Fuki IV; Ng DS; Rothblat GH; Rader DJ
    Circulation; 2009 Jul; 120(2):160-9. PubMed ID: 19564558
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting mitochondrial 18 kDa translocator protein (TSPO) regulates macrophage cholesterol efflux and lipid phenotype.
    Taylor JM; Allen AM; Graham A
    Clin Sci (Lond); 2014 Nov; 127(10):603-13. PubMed ID: 24814875
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Apolipoprotein AI) Promotes Atherosclerosis Regression in Diabetic Mice by Suppressing Myelopoiesis and Plaque Inflammation.
    Barrett TJ; Distel E; Murphy AJ; Hu J; Garshick MS; Ogando Y; Liu J; Vaisar T; Heinecke JW; Berger JS; Goldberg IJ; Fisher EA
    Circulation; 2019 Oct; 140(14):1170-1184. PubMed ID: 31567014
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Seeking novel targets for improving in vivo macrophage-specific reverse cholesterol transport: translating basic science into new therapies for the prevention and treatment of atherosclerosis.
    Julve J; Llaverias G; Blanco-Vaca F; Escolà-Gil JC
    Curr Vasc Pharmacol; 2011 Mar; 9(2):220-37. PubMed ID: 21143175
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cholesterol homeostatic mechanisms in transgenic mice with altered expression of apoproteins A-I, A-II and A-IV.
    Kalopissis AD; Chambaz J
    Int J Tissue React; 2000; 22(2-3):67-78. PubMed ID: 10937356
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Astaxanthin enhances ATP-binding cassette transporter A1/G1 expressions and cholesterol efflux from macrophages.
    Iizuka M; Ayaori M; Uto-Kondo H; Yakushiji E; Takiguchi S; Nakaya K; Hisada T; Sasaki M; Komatsu T; Yogo M; Kishimoto Y; Kondo K; Ikewaki K
    J Nutr Sci Vitaminol (Tokyo); 2012; 58(2):96-104. PubMed ID: 22790567
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elevation of systemic PLTP, but not macrophage-PLTP, impairs macrophage reverse cholesterol transport in transgenic mice.
    Samyn H; Moerland M; van Gent T; van Haperen R; Grosveld F; van Tol A; de Crom R
    Atherosclerosis; 2009 Jun; 204(2):429-34. PubMed ID: 19100548
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatic Forkhead Box Protein A3 Regulates ApoA-I (Apolipoprotein A-I) Expression, Cholesterol Efflux, and Atherogenesis.
    Li Y; Xu Y; Jadhav K; Zhu Y; Yin L; Zhang Y
    Arterioscler Thromb Vasc Biol; 2019 Aug; 39(8):1574-1587. PubMed ID: 31291759
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhanced atheroprotection and lesion remodelling by targeting the foam cell and increasing plasma cholesterol acceptors.
    Son SH; Goo YH; Choi M; Saha PK; Oka K; Chan LC; Paul A
    Cardiovasc Res; 2016 Feb; 109(2):294-304. PubMed ID: 26487692
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Arg123-Tyr166 domain of human ApoA-I is critical for HDL-mediated inhibition of macrophage homing and early atherosclerosis in mice.
    Holvoet P; Peeters K; Lund-Katz S; Mertens A; Verhamme P; Quarck R; Stengel D; Lox M; Deridder E; Bernar H; Nickel M; Theilmeier G; Ninio E; Phillips MC
    Arterioscler Thromb Vasc Biol; 2001 Dec; 21(12):1977-83. PubMed ID: 11742873
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Apolipoprotein A-V modulates multiple atherogenic mechanisms in a mouse model of disturbed clearance of triglyceride-rich lipoproteins.
    Grosskopf I; Shaish A; Afek A; Shemesh S; Harats D; Kamari Y
    Atherosclerosis; 2012 Sep; 224(1):75-83. PubMed ID: 22809445
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Coffee consumption enhances high-density lipoprotein-mediated cholesterol efflux in macrophages.
    Uto-Kondo H; Ayaori M; Ogura M; Nakaya K; Ito M; Suzuki A; Takiguchi S; Yakushiji E; Terao Y; Ozasa H; Hisada T; Sasaki M; Ohsuzu F; Ikewaki K
    Circ Res; 2010 Mar; 106(4):779-87. PubMed ID: 20075335
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.